Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation. 2023

Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
Infection, Immunity and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, and the Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.

The antigen presentation molecule MHC class I related protein-1 (MR1) is best characterized by its ability to present bacterially derived metabolites of vitamin B2 biosynthesis to mucosal-associated invariant T-cells (MAIT cells). Through in vitro human cytomegalovirus (HCMV) infection in the presence of MR1 ligand we investigate the modulation of MR1 expression. Using coimmunoprecipitation, mass spectrometry, expression by recombinant adenovirus and HCMV deletion mutants we investigate HCMV gpUS9 and its family members as potential regulators of MR1 expression. The functional consequences of MR1 modulation by HCMV infection are explored in coculture activation assays with either Jurkat cells engineered to express the MAIT cell TCR or primary MAIT cells. MR1 dependence in these activation assays is established by addition of MR1 neutralizing antibody and CRISPR/Cas-9 mediated MR1 knockout. Here we demonstrate that HCMV infection efficiently suppresses MR1 surface expression and reduces total MR1 protein levels. Expression of the viral glycoprotein gpUS9 in isolation could reduce both cell surface and total MR1 levels, with analysis of a specific US9 HCMV deletion mutant suggesting that the virus can target MR1 using multiple mechanisms. Functional assays with primary MAIT cells demonstrated the ability of HCMV infection to inhibit bacterially driven, MR1-dependent activation using both neutralizing antibodies and engineered MR1 knockout cells. This study identifies a strategy encoded by HCMV to disrupt the MR1:MAIT cell axis. This immune axis is less well characterized in the context of viral infection. HCMV encodes hundreds of proteins, some of which regulate the expression of antigen presentation molecules. However the ability of this virus to regulate the MR1:MAIT TCR axis has not been studied in detail.

UI MeSH Term Description Entries
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072336 Mucosal-Associated Invariant T Cells A subset of T-lymphocytes that are present in large numbers at MUCOUS MEMBRANES and respond to INFECTIONS. They express a conserved invariant T-CELL RECEPTOR ALPHA-CHAIN that enables them to respond to infections by sensing RIBOFLAVIN metabolites of pathogens. MAIT Cell,Mucosal-Associated Invariant T Cell,MAIT Cells,Cell, MAIT,Cells, MAIT,Mucosal Associated Invariant T Cell,Mucosal Associated Invariant T Cells
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D015778 Minor Histocompatibility Antigens Allelic alloantigens often responsible for weak graft rejection in cases when (major) histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the H-Y antigen. Histocompatibility Antigens, Minor,Minor Histocompatibility Antigen,Minor Histocompatibility Peptide,Minor Histocompatibility Peptides,Antigen, Minor Histocompatibility,Histocompatibility Antigen, Minor,Histocompatibility Peptide, Minor,Histocompatibility Peptides, Minor,Peptide, Minor Histocompatibility

Related Publications

Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
November 2018, Mucosal immunology,
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
May 2018, Immunology and cell biology,
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
February 2024, Brain, behavior, and immunity,
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
July 2016, European journal of immunology,
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
September 2022, The Journal of experimental medicine,
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
October 2019, Organic & biomolecular chemistry,
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
June 2017, Current opinion in immunology,
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
January 2020, Methods in molecular biology (Clifton, N.J.),
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
January 2013, PloS one,
Caroline L Ashley, and Brian P McSharry, and Hamish E G McWilliam, and Richard J Stanton, and Ceri A Fielding, and Rommel A Mathias, and David P Fairlie, and James McCluskey, and Jose A Villadangos, and Jamie Rossjohn, and Allison Abendroth, and Barry Slobedman
March 2024, Nature reviews. Immunology,
Copied contents to your clipboard!